Achieve life sciences, inc. (ACHV)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents [note 5]

12,156

16,664

7,375

10,446

7,320

9,515

11,755

15,280

4,165

5,284

8,021

13,916

15,690

15

11,800

10,581

18,913

34,310

42,477

48,001

25,278

27,897

48,950

40,614

28,630

14,593

12,950

18,749

18,628

18,075

11,362

13,842

56,852

28,517

15,723

20,876

23,533

Restricted cash [note 8 and 14]

-

-

-

-

-

-

-

-

222

222

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments [note 7]

-

-

-

-

2,345

5,089

1,390

-

-

-

-

-

760

-

20,655

-

-

20,876

23,460

12,185

15,091

-

5,057

-

8,922

24,629

33,827

38,243

45,961

57,308

73,711

83,806

54,469

36,410

53,533

54,536

61,574

Restricted cash [note 8 and 14]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

190

251

-

-

-

-

-

314

314

-

314

314

377

377

377

502

502

Short-term investments [note 4]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,147

27,201

-

-

-

-

19,160

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36

47

53

111

48

76

71

113

19

-

166

218

295

300

321

327

-

-

-

363

-

-

-

Amounts receivable

-

8

-

-

-

7

25

124

7

9

70

241

237

-

-

-

-

14

13

149

1,559

5,676

4,827

4,951

8,610

8,657

9,922

6,439

5,156

714

1,138

956

774

449

987

1,498

1,224

Prepaid expenses

-

-

-

-

-

926

349

168

352

393

535

307

765

3

-

-

-

1,987

-

-

-

-

-

-

-

-

-

-

3,385

3,755

9,292

5,970

2,079

1,210

3,353

1,397

2,485

Prepaid expenses and other assets

746

662

264

356

866

-

-

-

-

-

-

-

-

-

1,647

1,298

1,585

-

1,599

2,032

3,008

2,165

2,462

2,288

1,821

5,770

2,713

3,542

-

-

-

-

-

-

-

-

-

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

158

307

233

-

-

304

499

499

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

12,902

17,334

7,639

10,802

10,531

15,537

13,519

15,572

4,746

5,908

8,626

14,464

17,452

18

34,296

41,380

47,985

57,298

67,597

62,747

45,506

55,761

61,315

47,853

48,149

53,867

59,707

67,273

73,451

80,179

95,817

104,888

114,551

66,949

73,973

78,809

89,318

Restricted cash [note 5]

50

50

50

50

50

50

50

50

50

50

272

272

272

-

272

272

272

272

222

190

190

-

251

251

251

314

314

-

-

314

-

-

-

-

-

-

-

Property and equipment, net

52

57

64

71

80

35

32

42

18

59

94

129

166

-

493

534

546

602

380

406

416

257

312

354

349

397

443

496

437

371

223

226

161

180

198

207

87

Right-of-use assets [note 7]

285

329

372

414

455

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

293

187

190

185

97

118

141

101

135

309

415

13

13

-

13

12

38

37

38

13

272

273

773

1,274

1,075

1,111

1,175

1,225

1,152

1,152

1,132

2,903

509

509

509

509

513

License agreement [note 3 and 4]

2,031

2,087

2,143

2,199

2,254

2,310

2,365

2,421

2,477

2,532

2,588

-

-

2,755

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill [note 4]

1,034

1,034

1,034

1,034

1,034

1,034

1,034

1,034

1,034

1,034

1,034

-

-

1,034

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

16,647

21,078

11,492

14,755

14,501

19,084

17,141

19,220

8,460

9,892

13,029

14,878

17,903

3,807

35,074

42,198

48,841

58,209

68,237

63,356

46,384

56,291

62,651

49,732

49,824

55,689

61,639

69,308

75,354

82,016

97,172

108,017

115,221

68,015

74,680

79,525

89,918

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

184

859

574

707

694

144

458

251

420

213

495

233

359

95

1,043

559

592

1,343

1,779

302

988

72

1,562

1,341

923

139

39

130

-

1,329

-

-

-

-

-

-

-

Accrued liabilities other

174

304

424

342

545

748

755

966

532

438

1,297

1,056

834

1,121

602

622

909

641

811

954

1,014

863

-

-

-

500

-

-

-

-

-

-

-

-

-

-

-

Accrued clinical liabilities

571

387

737

892

2,086

1,199

667

782

774

877

162

50

342

-

7,114

7,703

8,450

9,966

9,968

10,478

9,665

13,462

-

-

-

11,284

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,167

13,249

13,041

-

11,334

9,273

-

4,180

-

-

-

-

-

-

-

Accrued compensation

419

1,116

1,206

855

488

1,168

1,071

750

592

458

343

254

210

-

1,422

1,328

744

1,267

1,610

1,252

731

1,333

1,109

981

904

1,705

1,357

-

-

1,541

-

-

-

-

-

-

-

Current portion of obligations [note 7]

-

-

-

16

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term obligations [note 7]

196

203

198

176

170

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Salaries Payable

-

-

-

-

-

-

-

-

-

-

-

-

-

1,028

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholder loans with related parties [note 13]

-

-

-

-

-

-

-

-

-

-

-

-

-

829

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued litigation settlement liability [note 3, note 7 and note 8]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,375

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued Compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,137

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,925

-

5,718

2,883

2,877

3,217

1,465

1,643

893

Current portion of long-term obligations [note 14]

-

-

-

-

-

-

11

11

-

27

31

46

55

-

57

57

51

52

53

54

52

236

1,114

1,106

1,097

1,092

1,090

1,089

1,088

1,084

1,451

1,440

1,429

1,417

1,406

1,384

1,314

Lease termination liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,250

1,250

1,250

1,250

1,250

1,250

3,250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,099

5,040

11,041

17,778

-

-

-

-

-

-

-

-

-

-

9,145

15,372

17,335

18,271

10,000

10,000

10,000

Proceeds received in advance [note 8]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,174

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability [note 7 and note 8 [f]]

-

-

-

-

-

-

-

-

-

-

3

114

180

-

350

971

438

1,105

2,836

2,967

2,537

3,002

3,975

320

935

214

548

1,087

1,988

3,422

5,359

7,667

9,311

7,881

6,248

14,828

15,269

Total current liabilities

1,544

2,869

3,139

2,988

3,999

3,270

2,962

2,760

2,318

2,013

2,331

1,753

1,980

3,073

10,588

13,865

14,533

20,664

29,348

35,035

16,237

22,218

20,927

20,171

16,900

14,934

14,368

12,716

11,001

11,556

21,673

27,362

30,952

30,786

19,119

27,855

27,476

Long-term obligations [note 7]

-

-

-

20

24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term obligations [note 7]

118

159

212

243

289

12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred collaboration revenue, net of current [note 4]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,036

9,866

11,622

Long-term obligations [note 14]

-

-

-

-

-

-

15

18

-

-

16

22

32

-

67

84

92

105

117

130

128

14

2,873

3,096

3,320

3,544

3,728

3,907

4,088

4,253

5,738

5,940

6,142

6,339

6,500

6,606

6,695

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

124

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

1,662

3,028

3,351

3,251

4,312

3,282

2,977

2,778

2,318

2,013

2,347

1,775

2,012

3,197

10,655

13,949

14,625

20,769

29,465

35,165

16,365

22,232

23,800

23,267

20,220

18,478

18,096

16,623

15,089

15,809

27,411

33,302

37,094

37,125

34,655

44,327

45,793

Commitments and contingencies [note 7]

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Convertible preferred stock, value

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, $0.001 par value, 150,000,000 shares authorized, 31,352,764 issued and outstanding at March 31, 2020 and 29,485,178 issued and outstanding at December 31, 2019, respectively.

43

41

19

19

18

18

16

15

13

12

11

30

30

-

30

29

30

29

30

24

22

22

21

15

15

15

15

15

15

15

15

14

15

10

10

10

10

Additional paid-in capital

63,962

63,709

50,628

50,318

41,455

41,161

35,887

34,926

21,840

20,556

19,581

213,662

213,450

2,667

212,843

212,977

212,058

211,590

211,187

196,067

191,889

191,373

190,469

173,149

169,272

168,242

167,899

167,011

166,156

165,395

164,828

163,901

163,078

108,986

108,660

108,224

107,579

Accumulated deficit

-49,024

-45,704

-42,510

-38,837

-31,288

-25,381

-21,744

-18,504

-15,716

-12,694

-8,915

-203,230

-200,230

-2,062

-191,097

-187,407

-180,518

-176,811

-175,087

-170,537

-164,527

-159,958

-154,276

-149,340

-142,325

-133,689

-127,011

-116,957

-108,537

-101,840

-97,737

-91,817

-87,602

-80,742

-71,173

-75,644

-66,069

Accumulated other comprehensive income

4

4

4

4

4

4

5

5

5

5

5

2,641

2,641

5

2,643

2,650

2,646

2,632

2,642

2,637

2,635

2,622

2,637

2,641

2,642

2,643

2,640

2,616

2,631

2,637

2,655

2,617

2,636

2,636

2,528

2,608

2,605

Total stockholders' equity

14,985

18,050

8,141

11,504

10,189

15,802

14,164

16,442

6,142

7,879

10,682

13,103

15,891

610

24,419

28,249

34,216

37,440

38,772

28,191

30,019

34,059

38,851

26,465

29,604

37,211

43,543

52,685

60,265

66,207

69,761

74,715

78,127

30,890

40,025

35,198

44,125

Total liabilities and stockholders' equity

16,647

21,078

11,492

14,755

14,501

19,084

17,141

19,220

8,460

9,892

13,029

14,878

17,903

3,807

35,074

42,198

48,841

58,209

68,237

63,356

46,384

56,291

62,651

49,732

49,824

55,689

61,639

69,308

75,354

82,016

97,172

108,017

115,221

68,015

74,680

79,525

89,918